

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 9.69156443 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.02343087 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 6.82268537 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.50152205 |
| 5 | regulation of B cell differentiation (GO:0045577) | 6.22448046 |
| 6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.06628182 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.04723383 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.88631251 |
| 9 | cellular response to zinc ion (GO:0071294) | 5.71902831 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 5.57819315 |
| 11 | regulation of superoxide anion generation (GO:0032928) | 5.10533826 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04767585 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.04767585 |
| 14 | B cell proliferation (GO:0042100) | 5.01076300 |
| 15 | serine transport (GO:0032329) | 4.91944291 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.84494945 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.84494945 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.84494945 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.84494945 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.84494945 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.84494945 |
| 22 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.70838139 |
| 23 | L-serine transport (GO:0015825) | 4.46385058 |
| 24 | negative regulation of B cell proliferation (GO:0030889) | 4.42415417 |
| 25 | cytidine deamination (GO:0009972) | 4.39554780 |
| 26 | cytidine metabolic process (GO:0046087) | 4.39554780 |
| 27 | cytidine catabolic process (GO:0006216) | 4.39554780 |
| 28 | B cell mediated immunity (GO:0019724) | 4.36717739 |
| 29 | regulation of B cell proliferation (GO:0030888) | 4.29347391 |
| 30 | neutrophil activation (GO:0042119) | 4.28058993 |
| 31 | regulation of histone H3-K9 methylation (GO:0051570) | 4.25635658 |
| 32 | mature B cell differentiation (GO:0002335) | 4.24174010 |
| 33 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.15474112 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 4.13277655 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 4.10678897 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 4.09145715 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 4.08602495 |
| 38 | negative regulation of histone methylation (GO:0031061) | 4.06255840 |
| 39 | V(D)J recombination (GO:0033151) | 4.04895641 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.99686384 |
| 41 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.93367761 |
| 42 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.93367761 |
| 43 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.93367761 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.91203052 |
| 45 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.89854339 |
| 46 | regulation of B cell apoptotic process (GO:0002902) | 3.89822494 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.87715114 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.87715114 |
| 49 | regulation of platelet aggregation (GO:0090330) | 3.87446089 |
| 50 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.87297505 |
| 51 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.86865505 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85203621 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.84633493 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.84633493 |
| 55 | response to type I interferon (GO:0034340) | 3.84251089 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.83138570 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.79745222 |
| 58 | detection of bacterium (GO:0016045) | 3.79209838 |
| 59 | granulocyte activation (GO:0036230) | 3.79085860 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.76815687 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.76815687 |
| 62 | positive T cell selection (GO:0043368) | 3.74890156 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.74024518 |
| 64 | negative thymic T cell selection (GO:0045060) | 3.68728534 |
| 65 | T cell migration (GO:0072678) | 3.65363187 |
| 66 | B cell activation (GO:0042113) | 3.64375392 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.64108249 |
| 68 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.62890733 |
| 69 | T cell lineage commitment (GO:0002360) | 3.62361200 |
| 70 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.62340420 |
| 71 | complement activation, classical pathway (GO:0006958) | 3.61193367 |
| 72 | lymphocyte homeostasis (GO:0002260) | 3.57473397 |
| 73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.54607762 |
| 74 | T cell selection (GO:0045058) | 3.53595890 |
| 75 | T cell homeostasis (GO:0043029) | 3.53330316 |
| 76 | B cell homeostasis (GO:0001782) | 3.52494888 |
| 77 | detection of other organism (GO:0098543) | 3.51307487 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49338817 |
| 79 | germinal center formation (GO:0002467) | 3.48545509 |
| 80 | negative regulation of bone resorption (GO:0045779) | 3.48521007 |
| 81 | lymph vessel development (GO:0001945) | 3.44488631 |
| 82 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.44169921 |
| 83 | positive regulation of B cell activation (GO:0050871) | 3.43553024 |
| 84 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.40711434 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40349484 |
| 86 | response to host immune response (GO:0052572) | 3.40349484 |
| 87 | T cell costimulation (GO:0031295) | 3.39685182 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38324433 |
| 89 | positive regulation of B cell proliferation (GO:0030890) | 3.37957907 |
| 90 | defense response to protozoan (GO:0042832) | 3.37476534 |
| 91 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.37045700 |
| 92 | negative T cell selection (GO:0043383) | 3.36936348 |
| 93 | lymphocyte costimulation (GO:0031294) | 3.34605791 |
| 94 | B cell differentiation (GO:0030183) | 3.33234302 |
| 95 | regulation of B cell activation (GO:0050864) | 3.32913776 |
| 96 | natural killer cell differentiation (GO:0001779) | 3.30360661 |
| 97 | vesicle targeting (GO:0006903) | 3.29049260 |
| 98 | hepatocyte apoptotic process (GO:0097284) | 3.26372779 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26199568 |
| 100 | response to protozoan (GO:0001562) | 3.24732841 |
| 101 | negative regulation of gene silencing (GO:0060969) | 3.23653959 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.20782825 |
| 103 | antimicrobial humoral response (GO:0019730) | 3.19431551 |
| 104 | humoral immune response (GO:0006959) | 3.18707284 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.17295416 |
| 106 | antibacterial humoral response (GO:0019731) | 3.16891480 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 3.16885084 |
| 108 | positive regulation of immunoglobulin production (GO:0002639) | 3.15935760 |
| 109 | respiratory burst (GO:0045730) | 3.14227538 |
| 110 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.14040613 |
| 111 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13824381 |
| 112 | regulation of germinal center formation (GO:0002634) | 3.13119336 |
| 113 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11771740 |
| 114 | response to host (GO:0075136) | 3.11771740 |
| 115 | response to host defenses (GO:0052200) | 3.11771740 |
| 116 | Peyers patch development (GO:0048541) | 3.11426452 |
| 117 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.11426452 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10713350 |
| 119 | mononuclear cell proliferation (GO:0032943) | 3.10268894 |
| 120 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.09645032 |
| 121 | lymphocyte proliferation (GO:0046651) | 3.09084203 |
| 122 | regulation of superoxide metabolic process (GO:0090322) | 3.08804374 |
| 123 | leukocyte homeostasis (GO:0001776) | 3.07149262 |
| 124 | response to interleukin-15 (GO:0070672) | 3.05872190 |
| 125 | positive regulation of mast cell activation (GO:0033005) | 3.03974394 |
| 126 | tolerance induction (GO:0002507) | 3.03877095 |
| 127 | cellular response to interleukin-15 (GO:0071350) | 3.01863992 |
| 128 | lymph node development (GO:0048535) | 3.01608872 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 3.00742363 |
| 130 | positive regulation of histone deacetylation (GO:0031065) | 3.00341307 |
| 131 | I-kappaB phosphorylation (GO:0007252) | 2.98483105 |
| 132 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96437105 |
| 133 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.95872912 |
| 134 | positive regulation of humoral immune response (GO:0002922) | 2.95775454 |
| 135 | activation of JUN kinase activity (GO:0007257) | 2.94567934 |
| 136 | positive regulation of type 2 immune response (GO:0002830) | 2.94363836 |
| 137 | immunoglobulin mediated immune response (GO:0016064) | 2.93659604 |
| 138 | positive regulation of interferon-beta production (GO:0032728) | 2.92146715 |
| 139 | cellular response to interferon-gamma (GO:0071346) | 2.92019275 |
| 140 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.89619675 |
| 141 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.89131723 |
| 142 | positive regulation of Rap GTPase activity (GO:0032854) | 2.88998898 |
| 143 | thymic T cell selection (GO:0045061) | 2.88376970 |
| 144 | positive regulation of protein homooligomerization (GO:0032464) | 2.87590298 |
| 145 | leukocyte proliferation (GO:0070661) | 2.86602458 |
| 146 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86375621 |
| 147 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.84236511 |
| 148 | myeloid dendritic cell activation (GO:0001773) | 2.83833658 |
| 149 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77888531 |
| 150 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75673007 |
| 151 | regulation of interferon-beta production (GO:0032648) | 2.74226877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.10682717 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.93173321 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.22672572 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 5.06546097 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.42369048 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.28953644 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.25838934 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.62205090 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.55701155 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.30782472 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.15945502 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.04692005 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94600582 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66889149 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.64116277 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62891252 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.52490318 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.50519368 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.47227242 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.43210681 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.33074651 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.30984814 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20729803 |
| 24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.06860783 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03446719 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00503853 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00051644 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98315618 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97881903 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87469533 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87304324 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86401911 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84357993 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83987041 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83506827 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79532218 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79200935 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77855368 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75668512 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75172171 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73437140 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63145877 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58396766 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.50243085 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48354006 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45775864 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44143633 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42846826 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42421191 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40497994 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36955544 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35663623 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35268094 |
| 54 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34938303 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34546244 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33906289 |
| 57 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33478767 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31325399 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30235650 |
| 60 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27780233 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26775081 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26016445 |
| 63 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24361081 |
| 64 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22197731 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22154750 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21092352 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18381868 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16382654 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08977703 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08384604 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05972161 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03687031 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02744883 |
| 74 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00358235 |
| 75 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96422661 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95855239 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95584494 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93896342 |
| 79 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.93862045 |
| 80 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93548970 |
| 81 | P300_27268052_Chip-Seq_Bcells_Human | 0.89086010 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87953395 |
| 83 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87531268 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86113191 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85544101 |
| 86 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.85439588 |
| 87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.85231558 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84225787 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84103659 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84052813 |
| 91 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.83566100 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83352041 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82985237 |
| 94 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82641479 |
| 95 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82401286 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.82330690 |
| 97 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.82016000 |
| 98 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.81903558 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.81683105 |
| 100 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81153445 |
| 101 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80737391 |
| 102 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.79947492 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79916228 |
| 104 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.77659914 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76659004 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74563100 |
| 107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72160895 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71714150 |
| 109 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.70950039 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70540072 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.70435224 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70228313 |
| 113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70163656 |
| 114 | GATA3_26560356_Chip-Seq_TH1_Human | 0.69870035 |
| 115 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.69184558 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.67795690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.52386549 |
| 2 | * MP0001800_abnormal_humoral_immune | 4.90233063 |
| 3 | MP0001790_abnormal_immune_system | 4.74832508 |
| 4 | MP0005387_immune_system_phenotype | 4.74832508 |
| 5 | MP0000685_abnormal_immune_system | 3.99429399 |
| 6 | MP0003303_peritoneal_inflammation | 3.99336354 |
| 7 | * MP0002452_abnormal_antigen_presenting | 3.73648508 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.08333751 |
| 9 | MP0002398_abnormal_bone_marrow | 3.06401550 |
| 10 | * MP0002723_abnormal_immune_serum | 3.04039320 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 3.02707429 |
| 12 | * MP0001819_abnormal_immune_cell | 2.95183656 |
| 13 | MP0005671_abnormal_response_to | 2.93301078 |
| 14 | MP0000689_abnormal_spleen_morphology | 2.79210686 |
| 15 | MP0000716_abnormal_immune_system | 2.77368580 |
| 16 | MP0006054_spinal_hemorrhage | 2.54051899 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.52397210 |
| 18 | MP0002722_abnormal_immune_system | 2.34370833 |
| 19 | MP0002429_abnormal_blood_cell | 2.29106056 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.13102289 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.08883224 |
| 22 | MP0005025_abnormal_response_to | 2.07414767 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.03861062 |
| 24 | MP0003436_decreased_susceptibility_to | 1.96484750 |
| 25 | MP0009785_altered_susceptibility_to | 1.85693260 |
| 26 | MP0000703_abnormal_thymus_morphology | 1.85114743 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 1.83017824 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 1.78348280 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.78167846 |
| 30 | MP0002419_abnormal_innate_immunity | 1.74408983 |
| 31 | MP0002006_tumorigenesis | 1.73943100 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.70232076 |
| 33 | MP0002405_respiratory_system_inflammati | 1.67197939 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.66782104 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.65544147 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.64761124 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.61758973 |
| 38 | MP0004381_abnormal_hair_follicle | 1.59421983 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.57878198 |
| 40 | MP0004947_skin_inflammation | 1.53479025 |
| 41 | MP0008057_abnormal_DNA_replication | 1.49357986 |
| 42 | MP0001873_stomach_inflammation | 1.48862145 |
| 43 | MP0002933_joint_inflammation | 1.45213788 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.41240474 |
| 45 | MP0004510_myositis | 1.40825359 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.39974855 |
| 47 | MP0003866_abnormal_defecation | 1.39105548 |
| 48 | MP0001853_heart_inflammation | 1.37957983 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.37591934 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.35375858 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.24674936 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.21035550 |
| 53 | MP0005310_abnormal_salivary_gland | 1.17952975 |
| 54 | MP0003077_abnormal_cell_cycle | 1.17186915 |
| 55 | MP0000371_diluted_coat_color | 1.13013767 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.11211591 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.09181336 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.08970895 |
| 59 | MP0002136_abnormal_kidney_physiology | 1.01804307 |
| 60 | MP0009278_abnormal_bone_marrow | 0.96226783 |
| 61 | MP0000490_abnormal_crypts_of | 0.94484965 |
| 62 | MP0005076_abnormal_cell_differentiation | 0.92452084 |
| 63 | MP0003172_abnormal_lysosome_physiology | 0.88033517 |
| 64 | MP0003693_abnormal_embryo_hatching | 0.87315085 |
| 65 | MP0003787_abnormal_imprinting | 0.86521257 |
| 66 | MP0003724_increased_susceptibility_to | 0.82912104 |
| 67 | MP0008469_abnormal_protein_level | 0.80736396 |
| 68 | MP0003111_abnormal_nucleus_morphology | 0.80262314 |
| 69 | MP0008260_abnormal_autophagy | 0.80208359 |
| 70 | MP0000350_abnormal_cell_proliferation | 0.75778734 |
| 71 | MP0003091_abnormal_cell_migration | 0.75416585 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.74616007 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.67569545 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.67569545 |
| 75 | MP0002163_abnormal_gland_morphology | 0.64862227 |
| 76 | MP0003045_fibrosis | 0.63719647 |
| 77 | MP0002928_abnormal_bile_duct | 0.63627391 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.62838345 |
| 79 | MP0000858_altered_metastatic_potential | 0.62674348 |
| 80 | MP0008058_abnormal_DNA_repair | 0.61460919 |
| 81 | MP0005621_abnormal_cell_physiology | 0.60804026 |
| 82 | MP0001663_abnormal_digestive_system | 0.60623119 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.60543946 |
| 84 | MP0008874_decreased_physiological_sensi | 0.60037844 |
| 85 | MP0000313_abnormal_cell_death | 0.59690867 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.57976175 |
| 87 | MP0006082_CNS_inflammation | 0.57271710 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.56907030 |
| 89 | MP0000249_abnormal_blood_vessel | 0.56779493 |
| 90 | MP0002083_premature_death | 0.56048078 |
| 91 | MP0001730_embryonic_growth_arrest | 0.55113400 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.54427076 |
| 93 | MP0002075_abnormal_coat/hair_pigmentati | 0.53777793 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.53262283 |
| 95 | MP0009763_increased_sensitivity_to | 0.52884651 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.52811987 |
| 97 | MP0003279_aneurysm | 0.52773396 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.52751648 |
| 99 | MP0009931_abnormal_skin_appearance | 0.52643773 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.52190249 |
| 101 | MP0002132_abnormal_respiratory_system | 0.52156297 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.51913106 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.51507959 |
| 104 | MP0000609_abnormal_liver_physiology | 0.50872479 |
| 105 | MP0005408_hypopigmentation | 0.50718572 |
| 106 | MP0002009_preneoplasia | 0.50662636 |
| 107 | MP0003252_abnormal_bile_duct | 0.50627854 |
| 108 | MP0005166_decreased_susceptibility_to | 0.50478761 |
| 109 | MP0010307_abnormal_tumor_latency | 0.50305704 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.49072592 |
| 111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47762212 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46684198 |
| 113 | MP0001919_abnormal_reproductive_system | 0.45742171 |
| 114 | MP0005384_cellular_phenotype | 0.45682420 |
| 115 | MP0003786_premature_aging | 0.44798296 |
| 116 | MP0005451_abnormal_body_composition | 0.44730210 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.44426337 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.44006455 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.43921935 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.43631344 |
| 121 | MP0001784_abnormal_fluid_regulation | 0.43369335 |
| 122 | MP0001186_pigmentation_phenotype | 0.42752569 |
| 123 | MP0001915_intracranial_hemorrhage | 0.42103506 |
| 124 | MP0000733_abnormal_muscle_development | 0.41765816 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.41110016 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.41056813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.84668619 |
| 2 | Cellulitis (HP:0100658) | 7.07170391 |
| 3 | Papilloma (HP:0012740) | 7.02470486 |
| 4 | Verrucae (HP:0200043) | 7.02470486 |
| 5 | Recurrent bronchitis (HP:0002837) | 6.58013047 |
| 6 | Gastrointestinal stroma tumor (HP:0100723) | 6.50170084 |
| 7 | Recurrent sinusitis (HP:0011108) | 5.92709115 |
| 8 | Colitis (HP:0002583) | 5.91685394 |
| 9 | Abnormality of B cell number (HP:0010975) | 5.90719618 |
| 10 | B lymphocytopenia (HP:0010976) | 5.90719618 |
| 11 | Recurrent viral infections (HP:0004429) | 5.16880696 |
| 12 | Small epiphyses (HP:0010585) | 5.09757434 |
| 13 | Meningitis (HP:0001287) | 5.02227991 |
| 14 | Inflammation of the large intestine (HP:0002037) | 4.94559802 |
| 15 | Chronic sinusitis (HP:0011109) | 4.94535023 |
| 16 | Gastrointestinal inflammation (HP:0004386) | 4.79700415 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.74442179 |
| 18 | Thyroiditis (HP:0100646) | 4.69797445 |
| 19 | IgM deficiency (HP:0002850) | 4.56920121 |
| 20 | Osteomyelitis (HP:0002754) | 4.29434948 |
| 21 | Lymphopenia (HP:0001888) | 4.17571758 |
| 22 | Emphysema (HP:0002097) | 4.14102417 |
| 23 | Recurrent pneumonia (HP:0006532) | 4.06707636 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.00081406 |
| 25 | Sepsis (HP:0100806) | 3.86481526 |
| 26 | Recurrent otitis media (HP:0000403) | 3.86152733 |
| 27 | Bronchitis (HP:0012387) | 3.80395950 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.78216162 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.63150867 |
| 30 | Mitral stenosis (HP:0001718) | 3.59299186 |
| 31 | Chronic otitis media (HP:0000389) | 3.52212493 |
| 32 | Vasculitis (HP:0002633) | 3.46146173 |
| 33 | Vertebral arch anomaly (HP:0008438) | 3.45410679 |
| 34 | IgG deficiency (HP:0004315) | 3.37753859 |
| 35 | Recurrent fungal infections (HP:0002841) | 3.35407811 |
| 36 | Restrictive lung disease (HP:0002091) | 3.34106386 |
| 37 | Flattened epiphyses (HP:0003071) | 3.22817747 |
| 38 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.21438668 |
| 39 | IgA deficiency (HP:0002720) | 3.14350555 |
| 40 | T lymphocytopenia (HP:0005403) | 2.98379031 |
| 41 | Abnormality of the prostate (HP:0008775) | 2.94874230 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.89188873 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.87493596 |
| 44 | Abnormality of the intervertebral disk (HP:0005108) | 2.86886082 |
| 45 | Skin rash (HP:0000988) | 2.86501943 |
| 46 | Combined immunodeficiency (HP:0005387) | 2.81650116 |
| 47 | Arthropathy (HP:0003040) | 2.81386930 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.78398913 |
| 49 | Abnormality of the fingertips (HP:0001211) | 2.72137616 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.69998523 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.69522056 |
| 52 | Urticaria (HP:0001025) | 2.62663025 |
| 53 | Irregular vertebral endplates (HP:0003301) | 2.61294872 |
| 54 | Abnormality of T cells (HP:0002843) | 2.60763728 |
| 55 | Lymphoma (HP:0002665) | 2.58426187 |
| 56 | Ulnar bowing (HP:0003031) | 2.58160898 |
| 57 | Absent epiphyses (HP:0010577) | 2.54020424 |
| 58 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.54020424 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51233330 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51233330 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.48737299 |
| 62 | Hypoplasia of the thymus (HP:0000778) | 2.44652813 |
| 63 | Leukopenia (HP:0001882) | 2.39596459 |
| 64 | Viral hepatitis (HP:0006562) | 2.30369843 |
| 65 | Obstructive lung disease (HP:0006536) | 2.27641063 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27641063 |
| 67 | Chest pain (HP:0100749) | 2.26200121 |
| 68 | Neutropenia (HP:0001875) | 2.24830939 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.24540589 |
| 70 | Eosinophilia (HP:0001880) | 2.22079811 |
| 71 | Recurrent skin infections (HP:0001581) | 2.21995865 |
| 72 | Skin ulcer (HP:0200042) | 2.20315757 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.12943757 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11928491 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.11071696 |
| 76 | Nasal polyposis (HP:0100582) | 2.09515188 |
| 77 | Increased IgM level (HP:0003496) | 2.08796925 |
| 78 | Eczematoid dermatitis (HP:0000976) | 2.03883768 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.01736515 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.00163656 |
| 81 | Hepatitis (HP:0012115) | 1.99380959 |
| 82 | Hypertensive crisis (HP:0100735) | 1.95869486 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 1.95767271 |
| 84 | Abnormality of the vertebral endplates (HP:0005106) | 1.93149568 |
| 85 | Abnormality of male internal genitalia (HP:0000022) | 1.92821013 |
| 86 | Barrel-shaped chest (HP:0001552) | 1.92627143 |
| 87 | Increased IgE level (HP:0003212) | 1.92626721 |
| 88 | Limited elbow extension (HP:0001377) | 1.90126123 |
| 89 | Thrombocytosis (HP:0001894) | 1.89439073 |
| 90 | Squamous cell carcinoma (HP:0002860) | 1.89367565 |
| 91 | Progressive external ophthalmoplegia (HP:0000590) | 1.87099647 |
| 92 | Pustule (HP:0200039) | 1.86952812 |
| 93 | Granulocytopenia (HP:0001913) | 1.86458846 |
| 94 | Encephalitis (HP:0002383) | 1.82512079 |
| 95 | Abnormality of eosinophils (HP:0001879) | 1.82507221 |
| 96 | Dehydration (HP:0001944) | 1.82079717 |
| 97 | Spontaneous hematomas (HP:0007420) | 1.81742795 |
| 98 | Fatigue (HP:0012378) | 1.81313389 |
| 99 | Basal cell carcinoma (HP:0002671) | 1.81251865 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.80610903 |
| 101 | Hematochezia (HP:0002573) | 1.78706683 |
| 102 | Premature loss of primary teeth (HP:0006323) | 1.76342982 |
| 103 | Vertebral clefting (HP:0008428) | 1.75232345 |
| 104 | Poikiloderma (HP:0001029) | 1.74254187 |
| 105 | Gingivitis (HP:0000230) | 1.73974104 |
| 106 | Pulmonary fibrosis (HP:0002206) | 1.73649927 |
| 107 | Optic neuritis (HP:0100653) | 1.71312787 |
| 108 | Retrobulbar optic neuritis (HP:0100654) | 1.71312787 |
| 109 | Villous atrophy (HP:0011473) | 1.68778859 |
| 110 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.68778859 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 1.66404275 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 1.66373695 |
| 113 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.65403822 |
| 114 | Deep palmar crease (HP:0006191) | 1.65186560 |
| 115 | Chronic diarrhea (HP:0002028) | 1.63781170 |
| 116 | Aortic regurgitation (HP:0001659) | 1.61926684 |
| 117 | Teleangiectasia of the skin (HP:0100585) | 1.61609547 |
| 118 | Arthralgia (HP:0002829) | 1.61130941 |
| 119 | Pulmonary infiltrates (HP:0002113) | 1.59035733 |
| 120 | Facial diplegia (HP:0001349) | 1.58072462 |
| 121 | Aqueductal stenosis (HP:0002410) | 1.56502983 |
| 122 | External ear malformation (HP:0008572) | 1.56013428 |
| 123 | Albinism (HP:0001022) | 1.55590324 |
| 124 | Amaurosis fugax (HP:0100576) | 1.54573691 |
| 125 | Elevated hepatic transaminases (HP:0002910) | 1.53892137 |
| 126 | Abnormality of the thymus (HP:0000777) | 1.53665461 |
| 127 | Acrocyanosis (HP:0001063) | 1.52124876 |
| 128 | Long eyelashes (HP:0000527) | 1.48482355 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.47368228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 6.88911672 |
| 2 | MAP4K1 | 5.72875357 |
| 3 | GRK6 | 4.50743981 |
| 4 | ERN1 | 3.46952238 |
| 5 | BLK | 3.13612464 |
| 6 | PRPF4B | 2.96924583 |
| 7 | SYK | 2.67487492 |
| 8 | CSF1R | 2.63677405 |
| 9 | RIPK4 | 2.45343511 |
| 10 | BTK | 2.15940776 |
| 11 | TLK1 | 2.15104346 |
| 12 | SMG1 | 2.02524544 |
| 13 | STK10 | 2.00757597 |
| 14 | LRRK2 | 1.89236028 |
| 15 | NEK9 | 1.67579376 |
| 16 | LYN | 1.66459630 |
| 17 | SIK2 | 1.63906731 |
| 18 | EEF2K | 1.60830468 |
| 19 | STK4 | 1.53546387 |
| 20 | TYK2 | 1.46982834 |
| 21 | MAP3K14 | 1.45777051 |
| 22 | CDK12 | 1.42400722 |
| 23 | EIF2AK3 | 1.39452238 |
| 24 | CDK19 | 1.36901392 |
| 25 | PIM1 | 1.34173034 |
| 26 | MAP3K13 | 1.32855906 |
| 27 | MAP3K9 | 1.30960025 |
| 28 | CSK | 1.30661579 |
| 29 | TRIB3 | 1.28013114 |
| 30 | TBK1 | 1.25101723 |
| 31 | BMPR2 | 1.24434446 |
| 32 | JAK1 | 1.22851308 |
| 33 | HCK | 1.22725693 |
| 34 | CDK9 | 1.15812294 |
| 35 | CLK1 | 1.15107330 |
| 36 | CDK4 | 1.12486630 |
| 37 | MST4 | 1.10277418 |
| 38 | FES | 1.10245957 |
| 39 | NEK2 | 1.09685442 |
| 40 | PASK | 1.08649411 |
| 41 | MARK3 | 1.03159421 |
| 42 | VRK1 | 1.01281483 |
| 43 | DYRK1B | 0.98594368 |
| 44 | FRK | 0.98060558 |
| 45 | ARAF | 0.94613648 |
| 46 | IKBKB | 0.94409550 |
| 47 | MAPK7 | 0.92007391 |
| 48 | FGFR3 | 0.91082548 |
| 49 | LCK | 0.90868296 |
| 50 | MATK | 0.90677029 |
| 51 | PRKCQ | 0.87869036 |
| 52 | TNK2 | 0.86027884 |
| 53 | ITK | 0.85298488 |
| 54 | NME2 | 0.83583436 |
| 55 | KIT | 0.81495750 |
| 56 | HIPK2 | 0.78679263 |
| 57 | ZAP70 | 0.78588057 |
| 58 | GRK1 | 0.77931408 |
| 59 | IRAK4 | 0.72482231 |
| 60 | PRKD2 | 0.69418101 |
| 61 | MELK | 0.68378567 |
| 62 | MAP3K8 | 0.67910536 |
| 63 | TEC | 0.67371821 |
| 64 | SIK3 | 0.67363260 |
| 65 | PKN2 | 0.66573769 |
| 66 | KSR2 | 0.66298973 |
| 67 | WNK1 | 0.66002383 |
| 68 | PRKCH | 0.65488842 |
| 69 | PRKD1 | 0.65277758 |
| 70 | BRD4 | 0.64821979 |
| 71 | SIK1 | 0.64216183 |
| 72 | DYRK3 | 0.63538159 |
| 73 | MAP2K3 | 0.63436241 |
| 74 | MAP2K1 | 0.63330737 |
| 75 | JAK3 | 0.60311235 |
| 76 | IKBKE | 0.59593993 |
| 77 | ICK | 0.59157745 |
| 78 | TGFBR2 | 0.58752889 |
| 79 | MAPK4 | 0.58569323 |
| 80 | BRAF | 0.56122324 |
| 81 | RPS6KB2 | 0.53248021 |
| 82 | RPS6KA4 | 0.52151223 |
| 83 | MAPK12 | 0.51726634 |
| 84 | FYN | 0.50501188 |
| 85 | TAF1 | 0.50337609 |
| 86 | MAP3K7 | 0.50209408 |
| 87 | JAK2 | 0.50008134 |
| 88 | FGFR2 | 0.49329946 |
| 89 | RAF1 | 0.48334258 |
| 90 | PIK3CG | 0.47877729 |
| 91 | PKN1 | 0.47641322 |
| 92 | SCYL2 | 0.47383611 |
| 93 | INSR | 0.45608027 |
| 94 | ALK | 0.45521878 |
| 95 | PDK1 | 0.45214265 |
| 96 | RPS6KA5 | 0.43232345 |
| 97 | IRAK3 | 0.42712986 |
| 98 | TESK2 | 0.42263114 |
| 99 | ZAK | 0.41906075 |
| 100 | TAOK2 | 0.41832856 |
| 101 | CSNK1D | 0.41164063 |
| 102 | CHUK | 0.40438760 |
| 103 | PDPK1 | 0.39500016 |
| 104 | MAPK11 | 0.39114008 |
| 105 | CDC42BPA | 0.38581078 |
| 106 | ABL1 | 0.37161358 |
| 107 | MAPKAPK2 | 0.37059456 |
| 108 | DAPK3 | 0.36434048 |
| 109 | MAP3K11 | 0.36386770 |
| 110 | SGK3 | 0.35917336 |
| 111 | NLK | 0.35494146 |
| 112 | MAP3K1 | 0.35325998 |
| 113 | FGFR4 | 0.35267980 |
| 114 | IRAK2 | 0.34249565 |
| 115 | CHEK1 | 0.33431773 |
| 116 | ATR | 0.33348252 |
| 117 | STK11 | 0.33026656 |
| 118 | PRKCD | 0.32940128 |
| 119 | FGR | 0.31675588 |
| 120 | EGFR | 0.28030334 |
| 121 | PRKCI | 0.28026560 |
| 122 | CDK6 | 0.27609832 |
| 123 | CDC7 | 0.27364407 |
| 124 | CCNB1 | 0.27283794 |
| 125 | STK24 | 0.27162955 |
| 126 | TAOK3 | 0.25312724 |
| 127 | AURKB | 0.22311028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.31053644 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.25198842 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.04532734 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.82313274 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.27368982 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.18054707 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.80852906 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.72287743 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.52700921 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.42112701 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.41636509 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25054248 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10129672 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.09860209 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02845821 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.01365824 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.88170183 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69433828 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63896371 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.60481239 |
| 21 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.56302919 |
| 22 | Alcoholism_Homo sapiens_hsa05034 | 1.54400886 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51973964 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46291656 |
| 25 | DNA replication_Homo sapiens_hsa03030 | 1.43214675 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37426840 |
| 27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.36311205 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30474688 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.28548461 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.25846155 |
| 31 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.23078200 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16855391 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15306186 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13835733 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13280717 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.08705329 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.07473337 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03277073 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01224441 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 0.96491140 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93183416 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92412216 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.91738668 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 0.90718286 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88987349 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.87677170 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87571220 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86258959 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84279413 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82667264 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.79743764 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73634942 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.72315267 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70517514 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70180330 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68723428 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 0.64740094 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64538867 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64334026 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63531973 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62386042 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61133634 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58222646 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.57334332 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57326112 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57101277 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56230938 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55085760 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.53799601 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.53315015 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.52905444 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52256238 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.52044125 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.52017765 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.49414131 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49213896 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48990943 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48750247 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48528037 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.48387865 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47484102 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44890339 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44818684 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.43302607 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41896330 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.41668760 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40462456 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.38393813 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37628499 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35839238 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35480447 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34983050 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.34851694 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30677744 |
| 95 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30194075 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29886549 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.29575931 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29069400 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28864891 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27754042 |
| 101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26535165 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25943505 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22741054 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22635447 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22235888 |
| 106 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21847820 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21712807 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20748199 |
| 109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.20724091 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19484914 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19176931 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19105962 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18833473 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15284876 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.13576402 |
| 116 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.13250314 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.11409633 |

